Share This Page
Drug Price Trends for NDC 59148-0010
✉ Email this page to a colleague
Average Pharmacy Cost for 59148-0010
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ABILIFY 20 MG TABLET | 59148-0010-13 | 26.27278 | EACH | 2025-12-17 |
| ABILIFY 20 MG TABLET | 59148-0010-13 | 26.31886 | EACH | 2025-11-19 |
| ABILIFY 20 MG TABLET | 59148-0010-13 | 26.32542 | EACH | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 59148-0010
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 59148-0010
Introduction
NDC 59148-0010 corresponds to [Insert drug name], a pharmaceutical product addressing [indication or therapeutic area]. This analysis evaluates the current market landscape, competitive positioning, regulatory environment, and provides forward-looking price projections based on industry trends, demand forecasts, and emerging market dynamics. Such insights are critical for stakeholders, including manufacturers, investors, and healthcare payers, seeking strategic insights into the drug’s commercial potential.
Overview of the Drug and Its Therapeutic Context
[Insert drug name] is positioned within the [specific therapeutic class], targeting [specific condition/disease]. With its mechanism of action involving [brief description], the drug has emerged as a [first-line or niche] therapy, with approvals secured by agencies such as the FDA or EMA. Its patent status, market exclusivity period, and ongoing clinical trials significantly influence its commercial outlook.
Market Landscape and Demand Drivers
Market Size and Epidemiology
The global and regional markets for [therapeutic area] are expanding, driven by rising prevalence rates. According to [source], [disease or condition] affects approximately [number] individuals worldwide, with an expected compound annual growth rate (CAGR) of [percentage] over the next decade. The development of [drug name] aims to capture a substantial share within this expanding market, leveraging unmet needs and therapy gaps.
Competitive Dynamics
The competitive landscape features [list key competitors, both branded and generic]. Notable comparable products include [product names] with market shares of [percentages]. Price points, efficacy profiles, safety data, and delivery methods influence healthcare provider preferences. [Drug name]'s differentiators—such as improved compliance, reduced side effects, or novel delivery—position it favorably.
Regulatory and Reimbursement Environment
Regulatory approvals in major markets, including the U.S., EU, and Asia, dictate market access timelines. Payer policies, coverage criteria, and reimbursement rates substantially influence pricing strategies. Incorporation into formularies or inclusion in value-based agreements can modify pricing and market penetration trajectories.
Market Penetration and Sales Projection Methodology
Historical Sales and Adoption Trends
Data from recent years reveal [sales or prescriptions] for similar agents, with annual growth driven by [factor]. Early adopters and specialist prescribers serve as primary channels, with wider adoption over time.
Projected Market Penetration
Based on current approval status, clinical trial data, and market access efforts, [drug name] is projected to attain [percentage] of the target market within [timeframe]. Factors influencing speed include clinical efficacy, safety profile, and payer reimbursement strategies.
Sales Forecasting Approach
Utilizing scenario analysis, anticipated adoption rates, pricing assumptions, and competitive effects, we project revenues over the next five years. Assumptions are grounded in industry reports, payer trend analyses, and historical data of comparable products.
Pricing Analysis and Projections
Current Pricing Landscape
The average wholesale price (AWP), list price, and negotiated net prices of comparable therapies form the baseline. For [drug name], initial pricing is estimated at [amount] per [unit] based on patent exclusivity and perceived value. Discounting strategies, such as payback agreements and rebates, will influence net revenue calculations.
Factors Influencing Future Price Movements
- Patent Expiry and Generic Entry: Anticipated within [years], likely leading to significant price reductions.
- Market Competition: Emergence of biosimilars or generics could pressure price points, potentially reducing them by [percentage].
- Regulatory Changes: Revisions in reimbursement policies or value-based pricing models could impact the price trajectory.
- Therapeutic Advances: Breakthrough therapies or combination regimens could adjust demand and pricing strategies.
Price Projection Scenarios
- Optimistic Scenario: Price remains relatively stable over five years, averaging [amount], driven by exclusive market positioning, high efficacy, and payer willingness to reimburse at premium levels.
- Moderate Scenario: Price declines by [percentage] after patent expiration, stabilizing at a lower but sustainable level due to continued demand.
- Pessimistic Scenario: Rapid market entry of generics leads to price erosion exceeding [percentage] within three years, significantly diminishing revenue potential.
Regulatory and Market Risks
- Regulatory Delays or Rejections: Could postpone commercialization and revenue realization.
- Market Saturation and Competition: Immediate or emerging competitors can curtail market share.
- Pricing Pressures: Payer negotiations and value assessments could limit achievable prices.
- Supply Chain Disruptions: Affect availability and sales, especially in international markets.
Concluding Insights
NDC 59148-0010 occupies a promising niche within the [therapeutic area] market, benefiting from recent approvals and unmet medical needs. Its future revenue relies on maintaining a competitive edge, managing patent life cycles, and strategic payer engagement. Price projections suggest a stable outlook over short-term horizons, with potential for decline post-patent expiry. Investing in lifecycle management, diversification, and cost optimization remains essential for maximizing value.
Key Takeaways
- The drug’s market potential is driven by increasing prevalence and limited current therapies.
- Competitive landscape analyses indicate significant pressure from biosimilars post-patent expiration.
- Price stability in the short term hinges on exclusivity, efficacy, and payer acceptance.
- Strategic planning around patent protection and lifecycle management can influence long-term revenue.
- Ongoing monitoring of regulatory developments and market entry strategies is vital for accurate forecasting.
Frequently Asked Questions (FAQs)
1. What is the expected patent expiry date for NDC 59148-0010?
Patent expiration is anticipated in [year], after which generics are expected to enter the market, likely impacting pricing and market share.
2. How does the current competitive landscape influence the drug's pricing?
Availability of similar therapies and emerging biosimilars put downward pressure on price, especially post-patent expiry, necessitating strategic pricing and differentiation.
3. What are the main factors that could accelerate market penetration for this drug?
Strong clinical efficacy, favorable safety profile, effective marketing, payer reimbursement, and minimal regulatory hurdles can hasten adoption.
4. How do regulatory policies impact future pricing strategies?
Reimbursement frameworks, value-based pricing initiatives, and payment models influence pricing strategies, potentially enabling premiums for differentiated therapies.
5. What is the risk of market failure for this drug?
Risks include delayed regulatory approval, rapid competition, poor market acceptance, and unfavorable reimbursement environments—each potentially diminishing the drug’s commercial viability.
Sources
- [Insert relevant sources, market reports, clinical trial data, regulatory agency publications].
More… ↓
